Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Adalimumab improves health-rel...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.

Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.

Bibliographic Details
Main Authors: Van der Heijde, D, Luo, M, Matsumoto, A, Mease, P, Torre-Alonso, J, Wordsworth, P, Wong, R, Davis, J, Grp, A
Format: Conference item
Published: 2005
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
Summary:

Similar Items

  • Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial
    by: van der Heijde, D, et al.
    Published: (2006)
  • Adalimumab improves physical functioning and work productivity in ankylosing spondylitis (AS) patients: Results from ATLAS.
    by: van der Heijde, D, et al.
    Published: (2006)
  • Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
    by: Revicki, D, et al.
    Published: (2008)
  • Improved physical functioning and work productivity in ankylosing spondylitis (AS) patients who were treated with adalimumab-ATLAS trial results
    by: Vanderheijde, D, et al.
    Published: (2007)
  • Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS.
    by: van der Heijde, D, et al.
    Published: (2006)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs